期刊文献+

老年高血压患者降压降脂是否加用阿司匹林

Is it necessary to add aspirin to antihypertension and lipid-lowering therapy in senile hypertensive patients
下载PDF
导出
摘要 目的观察高血压伴血脂升高的老年患者在降压降脂基础上是否加用阿司匹林对预防心脑血管并发症的影响。方法 260例原发性高血压伴血脂升高的老年患者,随机分为A组及B组,每组130例。A组给予降压降脂治疗,未加用阿司匹林;B组在降压降脂基础上加用阿司匹林。比较两组患者的治疗效果。结果两组组间治疗前后的收缩压、舒张压、低密度脂蛋白胆固醇(LDL-C)水平比较,差异均无统计学意义(P>0.05);两组组内治疗前后的收缩压、舒张压、LDL-C水平比较,差异均具有统计学意义(P<0.05)。两组患者心绞痛及脑梗死发生率比较,差异无统计学意义(χ~2=0.07,P>0.05)。两组患者改用降压药情况比较,差异无统计学意义(χ~2=0.223,P>0.05)。两组患者服用辛伐他汀未达标情况比较,差异无统计学意义(χ~2=0.053,P>0.05)。结论高血压伴血脂升高的老年患者仅服用降压药、降脂药就可以达到预防心绞痛、脑梗死等心脑血管并发症的目的 ,不需要加用阿司匹林。 Objective To observe the effect of adding aspirin to antihypertension and lipid-lowering therapy on prevention of cardiovascular and cerebrovascular complications in senile patients with essential hypertension and hyperlipidemia. Methods A total of 260 senile patients with essential hypertension and hyperlipidemia were randomly divided into group A and group B, with 130 cases in each group. Group A received antihypertension and lipid-lowering therapy without aspirin, and group B received aspirin on the basis of antihypertension and lipid-lowering therapy. Treatment effect in two groups was compared. Results Both groups had no statistically significant difference in systolic blood pressure, diastolic blood pressure, and low-density lipoprotein cholesterol (LDL-C) before and after treatment (P〉0.05). Both groups had statistically significant difference in systolic blood pressure, diastolic blood pressure, and LDL-C level before and after treatment (P〈0.05).Both groups had no statistically significant difference in incidence of angina and cerebral infarction (X2=0.07, P〉0.05). Both groups had no statistically significant difference in switching to antihypertensive drugs situation (X2=0.223, P〉0.05). Both groups had no statistically significant difference in taking simvastatin not up to standard (X2=0.053, P〉0.05). Conclusion Senile patients with essential hypertension and hyperlipidemia can achieve the purpose of preventing angina and cerebral infarction by taking antihypertensive drugs and lipid-lowering drugs only. Aspirin is not required.
出处 《中国实用医药》 2017年第30期115-117,共3页 China Practical Medicine
关键词 高血压 高血脂 心绞痛 脑梗死 降压 降脂 阿司匹林 老年 Hypertension Hyperlipidemia Angina Cerebral infarction Antihypertension Lipid- lowering Aspirin Senile
  • 相关文献

参考文献7

二级参考文献25

  • 1龚兰生,高平进.高血压治疗进展[J].中华内科杂志,1994,33(5):351-354. 被引量:52
  • 2彭化生,孙翠云,吕红霞.辛伐他汀与阿司匹林联合用药对高血压病患者颈动脉粥样硬化的干预作用[J].中国脑血管病杂志,2006,3(1):15-18. 被引量:16
  • 3王春波,胡大一,史旭波,朱正炎,朱晶岩,杨进刚.服用小剂量阿司匹林患者的阿司匹林抵抗[J].中国危重病急救医学,2006,18(4):219-223. 被引量:34
  • 4Pamukcu B. A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes[J]. J Thromb Thrombolysis, 2007, 23(3): 213-222.
  • 5Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardio- vascular disease[J].Am J Cardiol, 2001, 88(3): 230- 235.
  • 6Minuz P, Patrignani P, Gaino S, et al. Determinants of platelet activation in human essential hypertersion[J]. Hyper- tesion, 2004, 43(1): 64-70.
  • 7Mirkhel A, Peyster E, Sundeen J, et al.Frequency of aspirin resistance in a community hospital[J]. Am J Cardiol, 2006, 98(5): 577-579.
  • 8Fateh-Moghadarn S, Plockinger U, Cabeza N, et al. Prevalence of aspirin resistance in patients with type 2 diabetes[J]. Acta Diabetol, 2005, 42(2): 99-103.
  • 9Cabeza N, Li Z, Schulz C, et al. Surface expression of collagen receptor Fc receptor-γ/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells[J]. Diabetes, 2004, 53(8): 2117- 2121.
  • 10Watala C, Pluta J, Golanski J, et al. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin[J]. J Mol Med, 2005, 83(2): 148-158.

共引文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部